{
    "Trade/Device Name(s)": [
        "BinaxNOW\u00ae Staphylococcus aureus Test",
        "BinaxNOW\u00ae Staphylococcus aureus",
        "BinaxNOW\u00ae S. aureus",
        "Binax NOW\u00ae Staphylococcus aureus",
        "Binax NOW\u00ae S. aureus"
    ],
    "Submitter Information": "Binax, Inc.",
    "510(k) Number": "K090964",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060099"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JWX"
    ],
    "Summary Letter Date": "October 23, 2009",
    "Summary Letter Received Date": "October 30, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.2660"
    ],
    "Regulation Name(s)": [
        "Microorganism differentiation and identification device"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Staphylococcus aureus"
    ],
    "Specimen Type(s)": [
        "Blood culture (positive for Gram-positive cocci in clusters)"
    ],
    "Specimen Container(s)": [
        "Blood culture bottle"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic membrane assay"
    ],
    "Methodologies": [
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for BinaxNOW Staphylococcus aureus immunochromatographic rapid test for presumptive identification of S. aureus from positive blood cultures",
    "Indications for Use Summary": "Qualitative, in vitro immunochromatographic assay for the presumptive identification of Staphylococcus aureus directly from blood cultures positive for Gram-positive cocci in clusters; not intended for diagnosis or monitoring of treatment.",
    "fda_folder": "Microbiology"
}